"I think we need to find better ways to engage young people... HIV is a problem that can be solved, it's not just something you have to be afraid of, that you have to stay home, cowering from..." via The Leonard Lopate Show on WNYC
It's been over a year since The FDA approved Truvada, a once a day medication that prevents HIV infection. But why are so few people taking it? Dr. Robert Grant, a professor at the University of California San Francisco, talks about the drug and why it’s slow to catch on. He’s the lead scientist who developed the treatment, which is known as “pre-exposure prophylaxis” or PrEP.
No comments:
Post a Comment